Furthermore, a slightly elevated, yet not significant, expression of IGF2BP1 RNA was observed in HPV-positive cervical cancer samples deposited by the TCGA (median FPKM = 0.08), and compared to HPV-negative samples (median FPKM = 0.03, Figure 3C). This evidence concerns the gene IGF2BP1 and cervical cancer.